Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

IFN alpha-IFNAR-IN-1

IFN alpha-IFNAR-IN-1 is a nonpeptidic, low-molecular-weight inhibitor of the interaction between IFN-α and IFNAR. IFN alpha-IFNAR-IN-1 inhibits modified Vaccinia virus ankara (MVA) -induced IFN-α responses in murine bone-marrow-derived, Flt3- L-differentiated pDC cultures (BM-pDCs) (IC50=2-8 μM) [1].

Product Specifications

CAS Number

844882-93-5

UNSPSC

12352005

Target

IFNAR

Type

Reference compound

Related Pathways

Immunology/Inflammation

Applications

COVID-19-immunoregulation

Field of Research

Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/IFN-alpha-IFNAR-IN-1.html

Solubility

10 mM in DMSO

Smiles

CNCC1=CC=CC=C1SC2=C(C=CC=C3)C3=CC=C2

Molecular Formula

C18H17NS

Molecular Weight

279.40

References & Citations

[1]Geppert T, et al. Immunosuppressive small molecule discovered by structure-based virtual screening for inhibitors of protein-protein interactions. Angew Chem Int Ed Engl. 2012 Jan 2;51 (1) :258-61.

Shipping Conditions

Room temperature

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Citation 01

Arthritis Rheumatol. 2020 Jun;72 (6) :1003-1012.|Cell Rep. 2022 Nov 29;41 (9) :111738.|Free Radic Biol Med. 2022 Nov 20;193 (Pt 1) :202-212.|Front Immunol. 2019 May 3:10:980.|Sci Rep. 2016 Jul 14;6:29665.|Adv Healthc Mater. 2023 May;12 (13) :e2202830.|Arthritis Res Ther. 2022 Jul 19;24 (1) :170.|Biochem Biophys Res Commun. 2025 Nov 1:787:152767.|bioRxiv. 2025 Aug 12.|Cell Death Dis. 2020 Dec 11;11 (12) :1050.|Cell Mol Life Sci. 2022 Jan 20;79 (2) :83.|Cell Rep. 2023 Feb 28;42 (3) :112145.|Cell Rep. 2024 Apr 23;43 (4) :114088.|Clin Exp Immunol. 2021 Apr;204 (1) :64-77.|Exp Eye Res. 2021 Jan;202:108375.|Front Immunol. 2019 Oct 11;10:2391.|J Med Virol. 2023 Nov;95 (11) :e29237.|J Virol. 2025 Jan 23:e0153924.|Mol Oncol. 2023 Dec;17 (12) :2584-2602.|Nature. 2022 Sep;609 (7928) :785-792.|Pharmacol Res. 2023 Jan:187:106615.|PLoS Pathog. 2022 Feb 14;18 (2) :e1010301.|Viruses. 2022 Aug 18;14 (8) :1806.

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

CD44v6 (Marker of Tumor Metastasis) (2F10), CF647 conjugate, 0.1mg/mL
BNC471629-100 1x 100 µL

CD44v6 (Marker of Tumor Metastasis) (2F10), CF647 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
Consortin (CNST) Human Gene Knockout Kit (CRISPR)
KN420892 1 Kit

Consortin (CNST) Human Gene Knockout Kit (CRISPR)

Sign In for Pricing
View Details
MRP1 (ABCC1) Rabbit Monoclonal Antibody
TA423097 100 µL

MRP1 (ABCC1) Rabbit Monoclonal Antibody

Sign In for Pricing
View Details
Avenanthramide C
TRC-A794760-5MG 5 mg

Avenanthramide C

Sign In for Pricing
View Details
IPG -2 TMA+ Salt - yellow -green fluorescent potassium indicator
3013C 500 µg

IPG -2 TMA+ Salt - yellow -green fluorescent potassium indicator

Sign In for Pricing
View Details
PSMA7 (NM_002792) Human Over-expression Lysate
LY400987 100 µg

PSMA7 (NM_002792) Human Over-expression Lysate

Sign In for Pricing
View Details